Care Capital Investments III L.P.

CIK 1599355 · last filed 2015-05-12

Care Capital Investments III L.P. is a corporate insider who has filed 5 SEC Form 4 insider transactions across 3 companies since 2014. The most recent filing, for CLCD, was dated May 12, 2015. Across all open-market trades the lifetime net is +$13.5M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $839.6K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$839.6K

Companies

3

Total Filings

5

Lifetime Open-Market Net

$13.50M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
CoLucid Pharmaceuticals, Inc. (CLCD) Delisted	10%+ Owner	1,520,136	—	—	$0	1	2015-05-12
NERV	10%+ Owner	207,824	$4.04	$839.6K	-$14.94M	3	2015-03-20
NephroGenex, Inc. (NRX) Delisted	Director	2,148,365	—	—	$28.44M	1	2014-02-19

Recent Filings

5 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2015-05-12	CoLucid Pharmaceuticals, Inc. (CLCD) Delisted	Conv (C)	+6,182,156	$0	EDGAR
2015-03-20	NERV	Sell (S)	−3,620,100	-$20.83M	EDGAR
2015-01-26	NERV	Sell (S)	−1,446,336	-$7.39M	EDGAR
2014-07-09	NERV	Mixed	+2,740,503	$16.44M	EDGAR
2014-02-19	NephroGenex, Inc. (NRX) Delisted	Mixed	+12,723,291	$28.44M	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.